ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 41 filers reported holding ENOCHIAN BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,176 | +688.8% | 3,395 | 0.0% | 0.00% | – |
Q2 2023 | $1,924 | -79.2% | 3,395 | -66.5% | 0.00% | – |
Q1 2023 | $9,271 | +65.8% | 10,131 | +86.6% | 0.00% | – |
Q4 2022 | $5,592 | -100.0% | 5,429 | -40.8% | 0.00% | – |
Q3 2022 | $16,610,000 | +74.3% | 9,177 | +85.9% | 0.00% | – |
Q2 2022 | $9,528,000 | +1242.0% | 4,937 | +5640.7% | 0.00% | – |
Q1 2022 | $710,000 | -25.1% | 86 | -33.8% | 0.00% | – |
Q4 2021 | $948,000 | -2.2% | 130 | -9.7% | 0.00% | – |
Q3 2021 | $969,000 | -94.1% | 144 | -95.6% | 0.00% | – |
Q2 2021 | $16,326,000 | -17.0% | 3,285 | -40.9% | 0.00% | – |
Q1 2021 | $19,672,000 | +139.3% | 5,557 | +99.4% | 0.00% | – |
Q4 2020 | $8,222,000 | -26.7% | 2,787 | -11.1% | 0.00% | – |
Q3 2020 | $11,220,000 | +355.5% | 3,134 | +435.7% | 0.00% | – |
Q2 2020 | $2,463,000 | -80.7% | 585 | -86.2% | 0.00% | – |
Q1 2020 | $12,756,000 | -11.5% | 4,252 | +48.1% | 0.00% | – |
Q4 2019 | $14,417,000 | +1237.4% | 2,872 | +1365.3% | 0.00% | – |
Q3 2019 | $1,078,000 | +90.1% | 196 | +55.6% | 0.00% | – |
Q2 2019 | $567,000 | – | 126 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtu Financial LLC | 17,839 | $53,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 22,684 | $73,000 | 0.00% |
Tower Research Capital LLC (TRC) | 6,310 | $19,000 | 0.00% |
UNITED CAPITAL FINANCIAL ADVISORS, LLC | 53,901 | $159,000 | 0.00% |
Ameritas Investment Partners, Inc. | 355 | $1,000 | 0.00% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 21,280 | $63,000 | 0.00% |
UBS Group AG | 3,391 | $10,000 | 0.00% |
ALLIANCEBERNSTEIN L.P. | 27,900 | $82,000 | 0.00% |
RHUMBLINE ADVISERS | 14,932 | $44,000 | 0.00% |
FIRST TRUST ADVISORS LP | 34,978 | $103,000 | 0.00% |